Axon Partners lanzará un segundo fondo de fondos de ‘venture’ en 2021 ante el alto apetito inversor

by Axon Partners Group

La firma de inversión de capital riesgo Axon Partners prevé lanzar en 2021 un segundo fondo de fondos de ‘venture capital’ con exposición a tecnologías y ciencias de la vida, tras detectar el ...

Read more

Startups and Venture Capital behind the COVID-19 vaccines

by Axon Partners Group

It is worth noting that the development of innovation in Life Sciences is a costly process, sometimes requiring hundreds of millions. With Big Pharma currently going through a wave of lesser investmen...

Read more

Peptomyc announces a new equity financing round of 11.4M€ led by AurorA Science and supported by Alta Life Sciences, HealthEquity, CDTI and business angels

by Alta Life Sciences

Peptomyc is relying on a strong syndicate of life sciences investors. This investment was led by AurorA Science and substantially supported by existing investors including Alta Life Sciences, HealthEq...

Read more

SciClone joins the capital of AbilityPharma, supported by Inveready, Fitalent, Sodena and the CDTI, with an investment commitment of $3 million

by Inveready Asset Management

These investments are part of a financing round during the second half of 2020 in which AbilityPharma has raised 6.1 million € to finance its research on a treatment against pancreatic cancer.

Read more

Global Urology Leader Advanced MedTech Leads Devicare's USD$3 Million Series A Fundraising. Existing investors Emesa Capital, Ship2B and Juan Knuth participated in the funding round

by Fundación Ship2B

Advanced MedTech Holdings (AMTH), Southeast Asia’s largest medical device business, has announced it has led a USD$3million Series Afundingin Devicare, a Barcelona-based startup, to support itsdevel...

Read more

Almirall and Tyris Therapeutics, founded by Columbus Venture Partners, enter into strategic partnership to develop next generation gene therapies

by Columbus Venture Partners

Almirall, S.A., a global biopharmaceutical company based in Barcelona, and Tyris Therapeutics, a next generation gene therapy company founded by Columbus Venture Partners, have announced a strategic p...

Read more

CorWave, supported by Ysios Capital, Raises €35 Million in Series C Funding for Its Breakthrough Heart Pump; EIC Fund Joins as New Investor

by Ysios Capital

Bpifrance, Novo Holdings, Seventure, Sofinnova Partners and Ysios Capital, existing shareholders of CorWave and leading investors in life sciences, significantly increased their stake in the company. ...

Read more

Universal DX capta €14 millones para su test de cáncer de colon

by Universal DX

La ronda, cubierta por los propios accionistas de la empresa, permitirá a la compañía proseguir con sus ensayos clínicos, finalizar el test de detección de cáncer de colon este año con la inten...

Read more

RUTI Immune logra €1,6 millones a través de Capital Cell para desarrollar la vacuna RUTI® para COVID-19 y otras infecciones respiratorias

by Capital Cell

La compañía RUTI Immune, creada por la biotecnológica Archivel Farma, ha logrado captar 1,6 millones de euros a través de la plataforma de inversión colectiva Capital Cell para financiar su inves...

Read more

Alta Life Sciences leads an oversubscribed investment round into Inbiomotion to launch its diagnostic product in breast cancer

by Alta Life Sciences

The financing round is led by Alta Life Sciences Spain I FCR, a vehicle managed by Altamar Private Equity SGIIC. Existing investors including Institut Català de Finances (ICF) have also participated ...

Read more

Splice Bio, backed by Ysios Capital, Asabys Partners and Caixa Capital Risc, appoints Jean-Philippe Combal as Chairman of the Board of Directors

by Caixa Capital Risc

Splice Bio, a gene therapy company based on technology developed in the Muir Lab at Princeton University, announced today that it has appointed JeanPhilippe Combal as Chairman of its Board of Director...

Read more

Con un fondo de €35 millones, BeAble Capital ha conseguido crear 3 de cada 10 empresas industriales de base científica en España

by BeAble Capital

Con este importante dato económico, BeAble Capital hace un balance positivo de 2020, afianzándose como líder en España en inversión en ‘Science Equity’. Una modalidad de inversión, disruptiv...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Estrategias de Negociación con Inversor...

by Foro Capital Pymes

La negociación con inversores es un paso crucial y a menudo intimidan...

Photos Stream